Share This Page
Drug Price Trends for ALLERGY RELIEF-D TABLET
✉ Email this page to a colleague

Average Pharmacy Cost for ALLERGY RELIEF-D TABLET
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.58521 | EACH | 2025-05-21 |
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.58148 | EACH | 2025-04-23 |
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.57862 | EACH | 2025-03-19 |
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.56835 | EACH | 2025-02-19 |
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.55227 | EACH | 2025-01-22 |
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.55435 | EACH | 2024-12-18 |
ALLERGY RELIEF-D TABLET | 70000-0042-01 | 0.53133 | EACH | 2024-11-20 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for ALLERGY RELIEF D-12 TABLET
Market Overview of Allergy Treatment
The allergy treatment market is experiencing significant growth, driven by increasing allergic conditions and advancements in management techniques. By 2025, the allergy treatment market is expected to reach USD 22.76 billion and is projected to grow at a CAGR of 8.10% to reach USD 33.59 billion by 2030[4].
Demand and Prevalence of Allergies
Allergies are a common health issue, with over 100 million Americans affected by various types of allergies each year. Seasonal allergic rhinitis alone affects about 26% of adults and 19% of children in the United States[4]. This high prevalence ensures a steady demand for effective allergy relief medications.
Product Details: ALLERGY RELIEF D-12 TABLET
The ALLERGY RELIEF D-12 TABLET, similar to products like ZYRTEC-D, combines an antihistamine with a decongestant to provide relief from nasal congestion, sinus pressure, and other allergy symptoms. These tablets typically contain cetirizine HCl and pseudoephedrine, offering 12-hour relief from symptoms such as sneezing, itchy eyes, and runny nose[2].
Market Size and Growth
The OTC cough, cold, and allergy medicine market, which includes products like ALLERGY RELIEF D-12 TABLET, is expected to grow at a CAGR of 5.5% from 2022 to 2032, reaching a projected value of USD 66.54 billion by 2032[5]. The increasing accessibility and affordability of OTC products, along with the expansion of retail distribution channels, are key drivers of this growth.
Price Trends
As of the latest data, the price per unit of ALLERGY RELIEF D-12 TABLET is around $0.78, with minimal fluctuations over recent months[1]. This stability in pricing is indicative of a competitive market where prices are influenced by multiple factors, including production costs, regulatory approvals, and market demand.
Revenue Forecasting Techniques
For new pharmaceutical drugs, including allergy relief tablets, revenue forecasting involves several key steps:
- Estimating the potential market size based on the incidence and prevalence of the condition.
- Analyzing the addressable market size, including the percentage of diagnosed and treated patients.
- Conducting penetration studies, pricing analyses, and competitive analyses.
- Evaluating reimbursement and utilization patterns[3].
Key Trends Driving the Market
Several trends are driving the growth of the allergy treatment market:
- Advancements in Telemedicine and Wearable Devices: Improvements in telemedicine and allergy monitoring tools are enhancing patient care and treatment outcomes.
- Personalized Treatments: Tailoring allergy treatments to individual needs and sensitivities is becoming more prevalent.
- Regulatory Approvals: The shift from prescription to OTC status for many allergy medications is increasing accessibility and affordability[4][5].
Geographical Market Analysis
The allergy treatment market is globally distributed, with North America being the largest market and the Asia Pacific region experiencing the fastest growth. This geographical diversity indicates a broad and expanding market for allergy relief products[4].
Competitive Landscape
The market for OTC allergy medications is highly competitive, with major players such as Sanofi-Aventis, Johnson & Johnson, Reckitt Benckiser Group Plc., and Novartis AG. These companies invest heavily in research and development, marketing, and distribution, which helps in maintaining market share and driving growth[5].
Price Projections
Given the stable pricing trends and the growing demand for allergy relief medications, it is likely that the price per unit of ALLERGY RELIEF D-12 TABLET will remain relatively stable or experience minor adjustments based on market conditions. Here are some potential price projection scenarios:
- Short-Term (2025-2027): Prices are expected to remain stable around $0.78 per unit, with possible minor fluctuations based on production costs and market competition.
- Medium-Term (2028-2030): As the market continues to grow, prices might see a slight increase due to increased demand and potential rises in production costs, but this is expected to be minimal.
- Long-Term (2031-2032): The market's growth and the increasing prevalence of allergies could lead to a slight increase in prices, but this would be balanced by the competitive nature of the market and regulatory pressures to keep prices affordable[1][4][5].
Key Takeaways
- The allergy treatment market is growing significantly due to increasing allergic conditions and advancements in management techniques.
- The ALLERGY RELIEF D-12 TABLET is part of a larger market expected to reach USD 33.59 billion by 2030.
- Price trends for such products are stable, with minor fluctuations expected based on market conditions.
- Key trends include advancements in telemedicine, personalized treatments, and regulatory approvals for OTC status.
FAQs
Q: What is the expected market size of the allergy treatment market by 2030? A: The allergy treatment market is expected to reach USD 33.59 billion by 2030[4].
Q: What are the key ingredients in ALLERGY RELIEF D-12 TABLET? A: The tablets typically contain cetirizine HCl and pseudoephedrine, providing relief from nasal congestion and other allergy symptoms[2].
Q: How is the market for OTC allergy medications growing? A: The market is growing at a CAGR of 5.5% from 2022 to 2032, driven by accessibility, affordability, and expanded retail distribution channels[5].
Q: What trends are driving the growth of the allergy treatment market? A: Trends include advancements in telemedicine, personalized treatments, and regulatory approvals for OTC status[4].
Q: What is the current price per unit of ALLERGY RELIEF D-12 TABLET? A: As of the latest data, the price per unit is around $0.78[1].
Cited Sources:
- Drug Price Trends for ALLERGY RELIEF D-12 TABLET - DrugPatentWatch
- ZYRTEC-D® Allergy Medicine plus Decongestant - ZYRTEC
- Revenue Forecasting Techniques for New Pharmaceutical Drugs - iHealthcareAnalyst
- Allergy Treatment Market Analysis | Industry Forecast, Size & Report - Mordor Intelligence
- OTC Cough, Cold & Allergy Medicine Market 2032 - Fact.MR
More… ↓